High Evidence
Research Overview
HMG Research for IVF Outcomes
An evidence-based overview of research examining HMG in the context of ivf outcomes. This page synthesizes findings from peer-reviewed literature.
Research Summary
Multiple RCTs and meta-analyses show HP-hMG produces comparable or superior outcomes to recombinant FSH in IVF. The MEGASET-HR trial and others demonstrate 30% vs 27% ongoing pregnancy rates. The LH component may improve oocyte quality through more physiologic steroidogenesis.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. HMG may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.